Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 134-139, January 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raineri, R.
Right arrow Articles by Boutwell, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raineri, R.
Right arrow Articles by Boutwell, R. K.

Stimulation of the Phosphorylation of Mouse Epidermal Histones by Tumor-promoting Agents1

R. Raineri, R. C. Simsiman and R. K. Boutwell

McArdle Laboratory for Cancer Research, University of Wisconsin Medical Center, Madison, Wisconsin 53706

A single topical application of 0.017 µmole of the potent tumor promoter, 12-O-tetradecanoyl-phorbol-13-acetate, resulted in a stimulation of the phosphorylation of mouse epidermal histones with an early peak at 2 hr followed by peaks between 1 and 3 days after treatment. The effect of phorbol and two phorbol esters on histone phosphorylation was found to be related to their tumor-promoting activity as well as to their capacity to stimulate RNA and DNA synthesis. Stimulation of histone phosphorylation was slight following treatment with the weak promoter, phorbol-12,-13-dibenzoate, and nonexistent after treatment with phorbol, which has no tumor-promoting activity. A dose dependency relationship was established linking the ability of 12-O-tetradecanoyl-phorbol-13-acetate to stimulate histone phosphorylation with its ability to promote tumors.

Cycloheximide prevented the increase in histone phosphorylation caused by 12-O-tetradecanoyl-phorbol-13-acetate but had no effect on histone phosphorylation in control mice.

1 This work was supported in part by American Cancer Society Grant E-6M and by National Cancer Institute Grants CA-07175 and CA-05002.

Received 5/31/72. Accepted 10/11/72.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.